Corient Private Wealth’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Corient Private Wealth's ACLS Position: Q2 2026 in Review
Corient Private Wealth increased its Axcelis (ACLS) stake by 39% in Q2 2026, buying an estimated $326K and bringing the position to 7,792 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1571.
Corient Private Wealth first reported a position in ACLS in Q1 2023 and has held it in 11 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Corient Private Wealth held 7,792 shares of Axcelis worth $1.48M as of Q2 2026.
- Corient Private Wealth bought 2,197 Axcelis shares in Q2 2026, an estimated $326K.
- Axcelis made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1571 holding.
- Corient Private Wealth first reported a position in Axcelis in Q1 2023 and has held it in 11 quarters since.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.